|When:||« Back to Calendar February 27, 2014 @ 8:00 am - 10:30 am|
|Where:||Mass. Medical Society
860 Winter Street
|Add to Calendar Add to Google Cal|
|Member Cost:||$ 50|
|Nonmember Cost:||$ 85|
The past several years have not been the best of times for medtech start-up fundraising. The unreliability of FDA’s approval process and major shifts in payment policy have decreased interest in medical devices investment. How are early-stage medtech companies coping? What changes, if any, can be expected in the investment climate in the coming year? What’s the proper exit strategy for your medtech start-up?
This program will focus on how entrepreneurs and investors are confronting the fundraising challenges of today’s market. Attendees will receive a briefing on the year-end MoneyTree Survey Report from PWC and hear the views and perspectives from two panels of prominent entrepreneurs and investors.
Welcome & Introduction
Report: 2013 MedTech Financing Trends
Trends and Best Practices Panel – Entrepreneurs
MedTech Investment Trends Panel – Investors & Strategics
Al Brunett, Chief Patent Counsel, Vecna, Inc.
Marc E. Goldberg, Managing Director, BioVentures Investors
Michael A. Greeley, General Partner, Foundation Medical Partners
Moderated Discussion among All Panelists
|10:30 a.m.||Program Adjourns|
MassMEDIC gratefully acknowledges the support of Brown Rudnick, LLP, sponsor of this program.